Qin S - Search Results

1

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.

Li A, Yi M, Qin S, Song Y, Chu Q, Wu K. Li A, et al. Among authors: qin s. J Hematol Oncol. 2019 Apr 1;12(1):35. doi: 10.1186/s13045-019-0721-x. J Hematol Oncol. 2019. PMID: 30935414 Free PMC article. Review.

2

Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.

Yu S, Liu Q, Han X, Qin S, Zhao W, Li A, Wu K. Yu S, et al. Among authors: qin s. Exp Hematol Oncol. 2017 Nov 28;6:31. doi: 10.1186/s40164-017-0091-4. eCollection 2017. Exp Hematol Oncol. 2017. PMID: 29209558 Free PMC article. Review.

3

EGFR-TKIs resistance via EGFR-independent signaling pathways.

Liu Q, Yu S, Zhao W, Qin S, Chu Q, Wu K. Liu Q, et al. Among authors: qin s. Mol Cancer. 2018 Feb 19;17(1):53. doi: 10.1186/s12943-018-0793-1. Mol Cancer. 2018. PMID: 29455669 Free PMC article. Review.

4

Gut microbiome modulates efficacy of immune checkpoint inhibitors.

Yi M, Yu S, Qin S, Liu Q, Xu H, Zhao W, Chu Q, Wu K. Yi M, et al. Among authors: qin s. J Hematol Oncol. 2018 Mar 27;11(1):47. doi: 10.1186/s13045-018-0592-6. J Hematol Oncol. 2018. PMID: 29580257 Free PMC article. Review.

5

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.

Liu Q, Li A, Yu S, Qin S, Han N, Pestell RG, Han X, Wu K. Liu Q, et al. Among authors: qin s. J Hematol Oncol. 2018 Apr 10;11(1):53. doi: 10.1186/s13045-018-0597-1. J Hematol Oncol. 2018. PMID: 29636079 Free PMC article.

6

The regulation of cytokine signaling by retinal determination gene network pathway in cancer.

Zheng X, Liu Q, Yi M, Qin S, Wu K. Zheng X, et al. Among authors: qin s. Onco Targets Ther. 2018 Oct 4;11:6479-6487. doi: 10.2147/OTT.S176113. eCollection 2018. Onco Targets Ther. 2018. PMID: 30323623 Free PMC article. Review.

7

The role of neoantigen in immune checkpoint blockade therapy.

Yi M, Qin S, Zhao W, Yu S, Chu Q, Wu K. Yi M, et al. Among authors: qin s. Exp Hematol Oncol. 2018 Nov 16;7:28. doi: 10.1186/s40164-018-0120-y. eCollection 2018. Exp Hematol Oncol. 2018. PMID: 30473928 Free PMC article. Review.

8

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine.

Xu H, Jiao Y, Qin S, Zhao W, Chu Q, Wu K. Xu H, et al. Among authors: qin s. Exp Hematol Oncol. 2018 Dec 5;7:30. doi: 10.1186/s40164-018-0122-9. eCollection 2018. Exp Hematol Oncol. 2018. PMID: 30534474 Free PMC article. Review.

9

The role of gut microbiota in immune checkpoint inhibitor therapy.

Yi M, Qin S, Chu Q, Wu K. Yi M, et al. Among authors: qin s. Hepatobiliary Surg Nutr. 2018 Dec;7(6):481-483. doi: 10.21037/hbsn.2018.11.12. Hepatobiliary Surg Nutr. 2018. PMID: 30652094 Free PMC article. No abstract available.

10

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy.

Qin S, Li A, Yi M, Yu S, Zhang M, Wu K. Qin S, et al. J Hematol Oncol. 2019 Mar 12;12(1):27. doi: 10.1186/s13045-019-0718-5. J Hematol Oncol. 2019. PMID: 30866992 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,669 results

Search Page

Filters